View in EDS

Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.

Saved in:
Bibliographic Details
Title: Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.
Authors: Dimopoulos, M. A.1 mdimop@med.uoa.gr, Voorhees, P. M.2, Schjesvold, F.3, Cohen, Y. C.4, Hungria, V.5, Sandhu, I.6, Lindsay, J.7, Baker, R. I.8, Suzuki, K.9, Kosugi, H.10, Levin, M.-D.11, Beksac, M.12, Stockerl-Goldstein, K.13, Oriol, A.14, Mikala, G.15, Garate, G.16, Theunissen, K.17, Spicka, I.18, Mylin, A. K.19, Bringhen, S.20
Source: New England Journal of Medicine. 5/8/2025, Vol. 392 Issue 18, p1777-1788. 12p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first